{
  "schemaVersion": 1,
  "id": "research-124",
  "slug": "124-what-fda-s-2026-evaluation-categories-mean-for-ghk-cu",
  "title": "What FDA's 2026 evaluation categories mean for GHK-Cu",
  "catalogLabel": "GHK-Cu",
  "productCollection": "https://heritagebiolabs.com/research-library/products/ghk-cu",
  "productHandles": [
    "ghk-cu-564"
  ],
  "productUrls": [
    "https://heritagebiolabs.com/product/ghk-cu-564"
  ],
  "readingFocus": "Study findings",
  "readingFocusNote": "Reading focus is a navigational tag, not an evidence grade.",
  "wordCount": 266,
  "sourceYears": [
    2026
  ],
  "paragraphs": [
    "Peptides are short amino-acid chains connected by peptide bonds. Some, including the three-amino-acid peptide in GHK-Cu, can bind metal ions. GHK-Cu denotes its copper complex. The FDA's May 2026 update on nominated compounding substances addresses how the agency categorized certain forms of the substance for evaluation. That categorization concerns a regulatory process and is separate from evidence of a clinical effect. [1] [2]",
    "The FDA document records a change after a nominator clarified the scope of its submission. The agency returned GHK-Cu to Category 1 for non-injectable forms. Category 1 in this document describes nominated bulk substances under evaluation. The FDA separately identifies concerns about compounded injectable GHK-Cu, including uncertainty about the safety evidence in humans and the potential relevance of impurities or immune reactions. These are two distinct entries with different scopes. [1] [2]",
    "An entry for evaluation says that the agency is considering a nominated bulk substance. FDA approval of a finished drug would involve review of a particular product for a particular indication. A cosmetic study can provide information about appearance or skin measurements. Its conclusions are limited to the tested product and outcomes and do not answer the separate regulatory question. [1] [2]",
    "The May document is a dated account of the agency's evaluation categories. It records the scope of the nomination as it stood at that point. It helps a reader distinguish a nomination from an approved indication and shows why the scope of a regulatory entry matters. Describing one form as under evaluation does not establish the safety or effectiveness of other products that carry the same name. [1] [2]"
  ],
  "sources": [
    {
      "number": 1,
      "citation": "U.S. Food and Drug Administration. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act. U.S. Food and Drug Administration (publication 2026-05-14).",
      "url": "https://www.fda.gov/media/94155/download"
    },
    {
      "number": 2,
      "citation": "U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. U.S. Food and Drug Administration (publication 2026).",
      "url": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks"
    }
  ],
  "canonicalUrl": "https://heritagebiolabs.com/research-library/articles/124-what-fda-s-2026-evaluation-categories-mean-for-ghk-cu",
  "markdownUrl": "https://heritagebiolabs.com/research-library/data/articles/124-what-fda-s-2026-evaluation-categories-mean-for-ghk-cu.md",
  "jsonUrl": "https://heritagebiolabs.com/research-library/data/articles/124-what-fda-s-2026-evaluation-categories-mean-for-ghk-cu.json",
  "provenance": {
    "sourceArchive": "Peptide Research Articles - All 82 Volumes.zip",
    "sourceArchiveSha256": "9796bec477cbe2f8017dda81c7e58260985a13bdda1f934e8eb8d0549c2cada5",
    "sourceVolume": "Peptide Research Articles 025 - Fragment 176-191 and GHK-Cu.docx",
    "sourceArticleNumber": 124,
    "contentSha256": "b4e38ae33ce18a0e6112ac54061071e634c6373d908f3c075fb169a4faa2f033",
    "statement": "Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed."
  },
  "scope": "Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend."
}
